The organ in question is not entirely useless, of course. During childhood and adolescence, it serves a very important function. However, after that, it ceases its activity and shrinks. This is why ...

A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows ...

HPV-positive head and neck cancer cases have increased at epidemic rates in the United States over the past few decades.The study ...

CEO Richard Adcock used a presentation at the Citizens Life Sciences Conference to outline the company’s commercial progress with its lead product ANKTIVA and to highlight multiple upcoming regulatory ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Score Pharma, Inc., a biopharmaceutical company ...

Recommendation is based on peer-reviewed clinical data supporting long-term effectiveness and safety durability in patients with papillary-only disease treated with ANKTIVA plus BCG1.CULVER CITY, ...

ImmunityBio has achieved a significant milestone beyond its already approved drug, ANKTIVA. On March 13, 2026, the biotechnology firm announced the successful validation of a scalable manufacturing ...

Shares of ImmunityBio IBRX rose more than 7% on Friday after the company announced that it completed two manufacturing ...

Cancer is one of the most serious health problems in the world. Every year, millions of people are diagnosed with different ...

ImmunityBio Inc. (NASDAQ:IBRX) is one of the 10 Must-Watch Stocks Right Now. ImmunityBio surged by 7.29 percent on Friday to ...